Cite
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
MLA
Rhee, Hyungjin, et al. “Gadoxetic Acid-Enhanced MRI of Macrotrabecular-Massive Hepatocellular Carcinoma and Its Prognostic Implications.” Journal of Hepatology, vol. 74, no. 1, Jan. 2021, pp. 109–21. EBSCOhost, https://doi.org/10.1016/j.jhep.2020.08.013.
APA
Rhee, H., Cho, E.-S., Nahm, J. H., Jang, M., Chung, Y. E., Baek, S.-E., Lee, S., Kim, M.-J., Park, M.-S., Han, D. H., Choi, J.-Y., & Park, Y. N. (2021). Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. Journal of Hepatology, 74(1), 109–121. https://doi.org/10.1016/j.jhep.2020.08.013
Chicago
Rhee, Hyungjin, Eun-Suk Cho, Ji Hae Nahm, Mi Jang, Yong Eun Chung, Song-Ee Baek, Sunyoung Lee, et al. 2021. “Gadoxetic Acid-Enhanced MRI of Macrotrabecular-Massive Hepatocellular Carcinoma and Its Prognostic Implications.” Journal of Hepatology 74 (1): 109–21. doi:10.1016/j.jhep.2020.08.013.